Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
Roth MKM medical technology analyst holds analyst/industry conference call
4h ago
JNJ
SYK
Premium
The Fly
Protagonist Therapeutics, Johnson & Johnson submit icotrokinra NDA to FDA
10h ago
JNJ
PTGX
Premium
The Fly
Protagonist announces NDA submission by Johnson & Johnson for icotrokinra
10h ago
JNJ
PTGX
Premium
The Fly
Johnson & Johnson submits NDA to FDA for approval of icotrokinra
10h ago
JNJ
Premium
The Fly
Private Markets: JPMorgan initiates coverage of OpenAI
3d ago
DE
GS
Premium
Ratings
Balanced Outlook for Johnson & Johnson Amid Growth Prospects and Legal Uncertainties
3d ago
JNJ
Premium
The Fly
Johnson & Johnson price target raised to $190 from $180 at UBS
4d ago
JNJ
Premium
The Fly
Johnson & Johnson price target raised to $167 from $164 at Guggenheim
4d ago
JNJ
Premium
The Fly
Johnson & Johnson granted FDA Priority Review for TAR-200 NDA
4d ago
JNJ
Premium
The Fly
Johnson & Johnson price target raised to $175 from $161 at BofA
4d ago
JNJ
Premium
The Fly
Johnson & Johnson price target raised to $172 from $159 at Bernstein
5d ago
JNJ
Premium
The Fly
Johnson & Johnson price target raised to $176 from $165 at Barclays
5d ago
JNJ
Premium
Company Announcements
Johnson & Johnson Reports Strong Quarterly Growth
5d ago
JNJ
Premium
Ratings
Johnson & Johnson: Strong Performance Overshadowed by Biosimilar Competition and Litigation Risks
5d ago
JNJ
Premium
The Fly
Johnson & Johnson price target raised to $176 from $171 at Morgan Stanley
5d ago
JNJ
Premium
The Fly
Johnson & Johnson delivered ‘solid’ Q2, says Wells Fargo
5d ago
JNJ
Premium
Company Announcements
Johnson & Johnson’s Earnings Call Highlights Growth and Challenges
5d ago
JNJ
Premium
Ratings
Johnson & Johnson’s Strong Financial Performance and Strategic Positioning Justifies Buy Rating
5d ago
JNJ
Premium
Ratings
Cautious Optimism: Johnson & Johnson’s Strong Performance and Future Prospects Amid Legal Uncertainties
5d ago
JNJ
Premium
Ratings
Johnson & Johnson: Hold Rating Amid Mixed Signals and Uncertainties
5d ago
JNJ
Premium
Ratings
Johnson & Johnson: Balancing Strong Growth Projections with Uncertainties – Hold Rating Maintained
5d ago
JNJ
Premium
The Fly
Johnson & Johnson price target raised to $165 from $155 at Stifel
5d ago
JNJ
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
